These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 32627779

  • 1. Chemical sensing platforms for detecting trace-level Alzheimer's core biomarkers.
    Kim K, Lee CH, Park CB.
    Chem Soc Rev; 2020 Aug 07; 49(15):5446-5472. PubMed ID: 32627779
    [Abstract] [Full Text] [Related]

  • 2. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
    Prvulovic D, Hampel H.
    Clin Chem Lab Med; 2011 Mar 07; 49(3):367-74. PubMed ID: 21342022
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers.
    Lee JC, Kim SJ, Hong S, Kim Y.
    Exp Mol Med; 2019 May 09; 51(5):1-10. PubMed ID: 31073121
    [Abstract] [Full Text] [Related]

  • 4. Biosensors for Alzheimer's disease biomarker detection: A review.
    Shui B, Tao D, Florea A, Cheng J, Zhao Q, Gu Y, Li W, Jaffrezic-Renault N, Mei Y, Guo Z.
    Biochimie; 2018 Apr 09; 147():13-24. PubMed ID: 29307704
    [Abstract] [Full Text] [Related]

  • 5. Robust and Universal SERS Sensing Platform for Multiplexed Detection of Alzheimer's Disease Core Biomarkers Using PAapt-AuNPs Conjugates.
    Zhang X, Liu S, Song X, Wang H, Wang J, Wang Y, Huang J, Yu J.
    ACS Sens; 2019 Aug 23; 4(8):2140-2149. PubMed ID: 31353891
    [Abstract] [Full Text] [Related]

  • 6. Clinically accurate diagnosis of Alzheimer's disease via multiplexed sensing of core biomarkers in human plasma.
    Kim K, Kim MJ, Kim DW, Kim SY, Park S, Park CB.
    Nat Commun; 2020 Jan 08; 11(1):119. PubMed ID: 31913282
    [Abstract] [Full Text] [Related]

  • 7. Biochemical Markers in Alzheimer's Disease.
    Rabbito A, Dulewicz M, Kulczyńska-Przybik A, Mroczko B.
    Int J Mol Sci; 2020 Mar 14; 21(6):. PubMed ID: 32183332
    [Abstract] [Full Text] [Related]

  • 8. Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosis.
    Rezabakhsh A, Rahbarghazi R, Fathi F.
    Biosens Bioelectron; 2020 Nov 01; 167():112511. PubMed ID: 32858422
    [Abstract] [Full Text] [Related]

  • 9. [Molecular markers of Alzheimer disease early diagnostic: investigation perspectives of peripheral tissues.].
    Paltsev MA, Zuev VA, Kozhevnikova EO, Linkova NS, Kvetnaia TV, Polyakova VO, Kvetnoy IM.
    Adv Gerontol; 2017 Nov 01; 30(6):809-817. PubMed ID: 29608821
    [Abstract] [Full Text] [Related]

  • 10. Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer's Disease.
    Liu X, Liu Y, Liu Q.
    Biosensors (Basel); 2023 Apr 30; 13(5):. PubMed ID: 37232876
    [Abstract] [Full Text] [Related]

  • 11. Recent Electrokinetic and Microfluidic Strategies for Detection of Amyloid Beta Peptide Biomarkers: Towards Molecular Diagnosis of Alzheimer's Disease.
    Van Thanh Nguyen N, Taverna M, Smadja C, Mai TD.
    Chem Rec; 2021 Jan 30; 21(1):149-161. PubMed ID: 33112020
    [Abstract] [Full Text] [Related]

  • 12. Biological markers in Alzheimer's disease.
    Grundke-Iqbal I, Rolkova G, Konstekova E, Iqbal K.
    Bratisl Lek Listy; 2006 Jan 30; 107(9-10):359-65. PubMed ID: 17262988
    [Abstract] [Full Text] [Related]

  • 13. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
    Christl J, Verhülsdonk S, Pessanha F, Menge T, Seitz RJ, Kujovic M, Höft B, Supprian T, Lange-Asschenfeldt C.
    J Alzheimers Dis; 2019 Jan 30; 72(4):1119-1127. PubMed ID: 31683478
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
    Kang JH, Vanderstichele H, Trojanowski JQ, Shaw LM.
    Methods; 2012 Apr 30; 56(4):484-93. PubMed ID: 22503777
    [Abstract] [Full Text] [Related]

  • 15. Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings.
    Blennow K, Zetterberg H.
    Prog Mol Biol Transl Sci; 2019 Apr 30; 168():3-23. PubMed ID: 31699324
    [Abstract] [Full Text] [Related]

  • 16. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
    Pérez-Grijalba V, Romero J, Pesini P, Sarasa L, Monleón I, San-José I, Arbizu J, Martínez-Lage P, Munuera J, Ruiz A, Tárraga L, Boada M, Sarasa M.
    J Prev Alzheimers Dis; 2019 Apr 30; 6(1):34-41. PubMed ID: 30569084
    [Abstract] [Full Text] [Related]

  • 17. Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes.
    Carandini T, Arighi A, Sacchi L, Fumagalli GG, Pietroboni AM, Ghezzi L, Colombi A, Scarioni M, Fenoglio C, De Riz MA, Marotta G, Scarpini E, Galimberti D.
    Alzheimers Res Ther; 2019 Oct 15; 11(1):84. PubMed ID: 31615545
    [Abstract] [Full Text] [Related]

  • 18. Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ42 and T-Tau assays for Alzheimer's disease diagnosis.
    Bayart JL, Hanseeuw B, Ivanoiu A, van Pesch V.
    J Neurol; 2019 Sep 15; 266(9):2304-2311. PubMed ID: 31179518
    [Abstract] [Full Text] [Related]

  • 19. Biomarkers for Alzheimer's disease: current status and prospects for the future.
    Blennow K, Zetterberg H.
    J Intern Med; 2018 Dec 15; 284(6):643-663. PubMed ID: 30051512
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.